Arena Pharmaceuticals Inc

Overview

Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes drugs in multiple therapy areas. The company’s major product candidates include etrasimod, an oral sphingosine 1-phosphate receptor modulator intended for the treatment of gastroenterology and dermatology disease areas such as ulcerative colitis, eosinophilic esophagitis, Crohn’s disease, atopic dermatitis, and alopecia areata; Olorinab for pain associated with inflammatory bowel diseases and irritable bowel syndrome; APD418 for acute heart failure; and Ralinepag for the treatment of pulmonary arterial hypertension (PAH). It has collaborations with United Therapeutics, Eisai, Everest Medicines Limited, Boehringer Ingelheim and Beacon Discovery Inc. Arena is headquartered in San Diego, California, the US.
Key Stats
Address
6154 Nancy Ridge Dr, SAN DIEGO, California
Headquarters

United States of America

Contact

1 858 4537200

No of Employees

363

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

ARNA [NASD]

Revenue (2020)

$0 m

-100% (2020 vs 2019)
Net Income (2020)

$-405 m

-201.9% (2020 vs 2019)
Net Profit Margin

-126876 %

-257454.7% (2020 vs 2019)
Market Cap *

$3,631 m

EPS *

$-7.4

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Arena Pharmaceuticals IncAcadia Pharmaceuticals IncFinch Therapeutics Group Inc
Key Information
Headquarters United States of America United States of America United States of America
Headquarter City SAN DIEGO SAN DIEGO SOMERVILLE
Headquarter State/Province California California Massachusetts
No. of Employees 363 610 131
Entity Type Public Public Public

Products & Services

Arena discovers and develops innovative therapies that offers significant medical advances and new options for patients. The company’s key products include the following:

Products
  • Pipeline
  • Etrasimod, for Ulcerative Colitis, Crohn’s Disease, Atopic Dermatitis, Alopecia Areata and Eosiniphilic Esophagitis
  • Olorinab, for IBS Pain
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Garry A. Neil, M.D. Chairman Executive Board 2021 67 Dr. Garry Neil has been the Chairman of the company since February 2021. Prior to this, he served as the...
Paul D. Streck, M.D Senior Vice President - Clinical Development; Chief Medical Officer Senior Management 2020 - Mr. Paul D. Streck has been the Chief Medical Officer and Senior Vice President of Clinical Development of the company...
Laurie Stelzer Chief Financial Officer; Executive Vice President Senior Management 2020 52 Ms. Laurie Stelzer has been the Executive Vice President and Chief Financial Officer of the company since February 2020. Recently...
Robert Lisicki Executive Vice President; Chief - Commercial Officer Senior Management 2018 54 Mr. Robert Lisicki has been the Executive Vice President and Chief Commercial Officer since 2018. Recently, he served as the...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In July, the company signed a strategic collaboration with Aristea Therapeutics for the clinical development…
2021 New Product Approvals In June, the company secured the US FDA's Orphan Drug Designation status for its etrasimod…
2020 Regulatory Approval In January, the company received fast track designation from the US FDA for its APD418,…
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2018 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2017 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Arena Pharmaceuticals GmbH

Address

Gotthardstrasse 3
Switzerland

Telephone

41 41 5522670

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
27 Jul 2021 Arena Pharma Enters into Agreement with Aristea Therapeutics Partnership Aristea Therapeutics Inc; Arena Pharmaceuticals Inc
27 Jul 2021 Aristea Therapeutics Raises USD63 Million in Series B Financing Venture Financing Arena Pharmaceuticals Inc; Fidelity Management & Research Company; Tekla Capital Management LLC; Novo Holdings AS Aristea Therapeutics Inc
28 Oct 2020 Longboard Pharma Raises USD56 Million in Financing Private Equity Highside Capital Management; T Rowe Price Associates Inc; HBM Healthcare Investments AG; Farallon Capital Management LLC; Cormorant Asset Management LLC; Arena Pharmaceuticals Inc Longboard Pharmaceuticals Inc
27 May 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
02 Jan 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
12 Nov 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

71

Active Jobs

29

Posted

26

Closed

Job Trends

Latest Jobs

Job title Company Country
Director, ePMO Special Projects Arena Pharmaceuticals Inc United States
Safety Physician - Director, Safety and Pharmacovigilance Arena Pharmaceuticals Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar